NCT05206864View on ClinicalTrials.gov

Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

January 5, 2022

Study Completion Date

February 5, 2022

Conditions
Healthy
Interventions
OTHER

Medical Food: SBD111

One capsule administered twice daily with morning and evening meals for 28 days

OTHER

Placebo

One capsule administered twice daily with morning and evening meals for 28 days

Trial Locations (1)

02131

Hinda and Arthur Marcus Institute for Aging Research, Boston

All Listed Sponsors
collaborator

Hebrew SeniorLife

OTHER

lead

Solarea Bio, Inc

INDUSTRY

NCT05206864 - Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults | Biotech Hunter | Biotech Hunter